CASI Pharmaceuticals Inc
NASDAQ:CASI 11:07:27 AM EDT
Earnings Announcements
Casi Pharmaceuticals Announces First Quarter 2022 Financial Results
Published: 05/12/2022 11:17 GMT
CASI Pharmaceuticals Inc (CASI) - Casi Pharmaceuticals Announces First Quarter 2022 Financial Results.
Q1 Revenue $9.0 Million.
Qtrly Loss per Share $0.06.
Q1 Revenue $9.0 Million.
Qtrly Loss per Share $0.06.
Revenue is expected to be $7.87 Million
Adjusted EPS is expected to be -$0.06
Next Quarter Revenue Guidance is expected to be $10.35 Million
Next Quarter EPS Guidance is expected to be -$0.06
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.06
Next Quarter Revenue Guidance is expected to be $10.35 Million
Next Quarter EPS Guidance is expected to be -$0.06
More details on our Analysts Page.